Reach Us +1-217-403-9671
Bioequivalence Anticancers | List of High Impact Articles | PPts | Journals | Videos
Journal of Bioequivalence & Bioavailability

ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability

Bioequivalence Anticancers

Bioequivalence Anticancers

Search results for
Bioequivalence Anticancers

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

  • 18th World Pharma Congress
    October 18-20, 2018 Warsaw, Poland

Relevant Topics

Bioequivalence studies are required to be conducted using cancer patients for biosimilar drugs. Both pharmacokinetic and pharmacodynamic endpoints need to be generally investigated in biosimilar clinical trials. The test and innovative drugs are called bioequivalent if the two drugs have the same bioavailability.

A phase I trial should select pharmacodynamic markers that demonstrate the therapeutic efficacy of the drug, and should compare the pharmacodynamic effect of the test and innovative drugs in a population where the possible differences can best be observed.

Related Journals of Bioequivalence Anticancers

Bioequivalence Study Journal, MOJ Bioequivalence & Bioavailability, Journal of Bioequivalence & Bioavailability, International Journal of BioAnalytical Methods & BioEquivalence Studies, Asian journal of Pharmaceutical Care, Bioanalytical Methods & Bioequivalence Studies, Clinical & Experimental Pharmacology, Enliven: Biosimilars and Bioavailablity, Cardiovascular Pharmacology: Open Access, Chemical Speciation & Bioavailability, Pharmaceutical Regulatory Affairs: Open Access.

Bioequivalence Anticancers

Speaker PPTs